Abstract B06: p53 status directs choice of molecularly enhanced chemotherapy to achieve synthetic lethality in endometrial cancer

Abstract

Peer reviewed

K Thiel, X Meng, H Reyes and K Leslie

Molecular cancer therapeutics, Vol.12(5_Supplement), pp.B06-B06

05/01/2013

DOI: 10.1158/1535-7163.PMS-B06

View Online

Title: Subtitle: Abstract B06: p53 status directs choice of molecularly enhanced chemotherapy to achieve synthetic lethality in endometrial cancer
Creators: K Thiel - University of Iowa
X Meng - University of Iowa
H Reyes - University of Iowa
K Leslie - University of Iowa
Resource Type: Abstract
Publication Details: Molecular cancer therapeutics, Vol.12(5_Supplement), pp.B06-B06
DOI: 10.1158/1535-7163.PMS-B06
ISSN: 1535-7163
eISSN: 1538-8514
Language: English
Date published: 05/01/2013
Academic Unit: Obstetrics and Gynecology; Pathology
Record Identifier: 9984201119602771

2 Record Views